- Menu prices
- 250 mg $150; 500 mg $250; 1,000 mg $400
- Provider time estimates
- Up to 2 hours; 2–4 hours; 3–6 hours respectively
- Mobile service
- Confirm availability and any home-visit charge
Three menu choices with separate prices
Drip Okoboji lists NAD+ infusion services identified as 250 mg for $150, 500 mg for $250 and 1,000 mg for $400. These figures describe the practice's advertised appointment options. They are not a recommendation to select a particular amount or evidence that a larger menu entry produces a better result.
We review these choices together as variants of the local IV service, rather than creating three nearly identical product pages. The appropriate clinical plan may differ from a reader's initial selection. Ask the practice which preparation and assessment correspond to the proposed visit before using the menu as a complete treatment specification.
Time belongs beside the price
The service page asks readers to allow up to two hours for the 250 mg entry, two to four hours for the 500 mg entry and three to six hours for the 1,000 mg entry. Those are provider estimates, not appointment durations independently measured by this publication. Confirm the booking window and any preparation time with the practice.
Longer time estimates can matter for practical planning, transportation and the amount of a day committed to an appointment. They do not measure the benefit of the treatment. A comparison with a brief injection or a delivered nasal bottle should preserve the difference in service and setting instead of treating all NAD+ prices as equivalent purchases.
Office and home visits need different quotes
The practice is based in Spirit Lake and advertises local home visits within the Lakes Area. Its published home-visit fee is $50, with a group waiver whose threshold should be confirmed because the pages use different wording. Ask whether the selected infusion can be provided at the intended address and what total applies.
Also clarify whether the advertised infusion charge includes screening, supplies and every required clinical service. The existence of a separate peptide consultation on the menu does not establish that it is automatically required or included for this appointment. Obtain an itemized answer rather than adding an assumed fee or assuming all unlisted costs are zero.
A service listing is not evidence of a health outcome
The provider links NAD+ to energy, mental clarity and recovery. Those are advertised wellness goals. The NAD+ IV pilot in our source register does not establish the full range of commercial claims, and this review did not identify an independent trial showing that these particular local infusion services improve those outcomes predictably.
Discuss the intended purpose, evidence, sourcing and follow-up with the responsible clinician. If a compounded preparation is used, ask about its pharmacy and quality controls, keeping those questions separate from convenience and price. Drip Okoboji offers useful menu transparency; the final decision still requires a confirmed appointment total and an individualized assessment rather than a choice based on the largest listed amount or the lowest cost per milligram.
Sources & further reading
Official pages and evidence consulted for this article. Checked October 11, 2026. Provider pages establish advertised terms; they do not independently establish effectiveness.
- Drip Okoboji: current booking menu Provider
- Drip Okoboji: service descriptions Provider
- Drip Okoboji: local appointments, payment and home visits Provider
- Grant et al. 2019: Human plasma and urine metabolome during NAD+ IV infusion Clinical research
- FDA: Ingredients suitable for sterile compounding Regulator